Novavax
74,187
$105.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$105.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$9.96 (+10.56%) Today
+$1.18 (+1.13%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Novavax and other stocks, options, ETFs, and crypto commission-free!
About NVAX
Novavax, Inc. Common Stock, also called Novavax, is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. Read More It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. The firm's vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Employees
165
Headquarters
Gaithersburg, Maryland
Founded
1987
Market Cap
6.05B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.82M
High Today
$113.98
Low Today
$95.26
Open Price
$95.33
Volume
8.64M
52 Week High
$113.98
52 Week Low
$3.54
Collections
NVAX News
MarketWatchJul 7
Novavax's 30% surge boosts biotech ETFs to best day in weeks
Exchange-traded funds with exposure to biotech stocks rocketed higher Tuesday on hopeful news about treatments for COVID-19. The ETFMG Treatments, Testing and A
NVAX Earnings
-$1.69
-$1.13
-$0.56
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 5, After Hours
You May Also Like
More NVAX News
BloombergJul 7
Novavax Covid Vaccine Gets $1.6 Billion in U.S. Funding
(Bloomberg) -- Novavax Inc., one of the front-runners in the race to develop a Covid-19 vaccine, will receive $1.6 billion from the U.S. government, the biggest
CNBCJul 7
Stocks making the biggest moves in the premarket: Novavax, Regeneron, Square, Nvidia & more
Take a look at some of the biggest movers in the premarket:
Novavax (NVAX) – Novavax was awarded $1.6 billion in funding from "Operation Warp Speed," the gover
ReutersJul 7
BRIEF-Novavax Announces $1.6 Billion Funding From Operation Warp Speed
July 7 (Reuters) - Novavax Inc:
* NOVAVAX ANNOUNCES $1.6 BILLION FUNDING FROM OPERATION WARP SPEED
* NOVAVAX INC - OWS AWARD FUNDS LARGE-SCALE MANUFACTURING O
